IBX imagion biosystems limited

UK study proof IBX sits well for cancer treatment

  1. 836 Posts.
    lightbulb Created with Sketch. 429
    A UK study called Tracer X over 9 years with 420 patients now published in the nature journal reveals late stage cancer tumors infinite ability to evolve making it near impossible to treat if left to late. The report states that early detection is the only way to beat it.

    https://www.bbc.com/news/health-65252510

    IBX sits very well into this early detection requirement with other methods but it does have some big advantages. Namely it knows its image is a cancer, its non invasive, non-radioactive, cheaper and quicker.
    Biopsy is slower, expensive and invasive. PETs is radioactive, expensive and inconclusive.
    A blood test yes but where is it and how advanced.

    You have all these choices which would you choose?

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.3¢
Change
-0.002(5.71%)
Mkt cap ! $8.129M
Open High Low Value Volume
3.6¢ 3.6¢ 3.3¢ $188.7K 5.512M

Buyers (Bids)

No. Vol. Price($)
10 1917834 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 42530 1
View Market Depth
Last trade - 16.10pm 16/09/2025 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.